V015-1352 Screening compound: 2-[4-phenoxy-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline

V015-1352 Screening compound: 2-[4-phenoxy-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline
V015-1352 Screening compound: 2-[4-phenoxy-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-1352
2-[4-phenoxy-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-1352

Molecular Formula

C27H26N6O2 (C27 H26 N6 O2)

Compound Name

2-[4-phenoxy-2-(piperidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidine-6-carbonyl]quinoxaline

IUPAC name

2-[4-phenoxy-2-(piperidin-1-yl)-5H6H7H8H-pyrido[43-d]pyrimidine-6-carbonyl]quinoxaline

SMILES

O=C(c1nc2ccccc2nc1)N(CCc1nc(N2CCCCC2)n2)Cc1c2Oc1ccccc1

InChI

InChI=1S/C27H26N6O2/c34-26(24-17-28-22-11-5-6-12-23(22)29-24)33-16-13-21-20(18-33)25(35-19-9-3-1-4-10-19)31-27(30-21)32-14-7-2-8-15-32/h1,3-6,9-12,17H,2,7-8,13-16,18H2

InChI Key

YXXPCBYJFIPZLH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19979927

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

466.54

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.192

Distribution Coefficient, logD

5.192

Water Solubility, LogSw

-5.07

Polar Surface Area

63.960

Acid Dissociation Constant (pKa)

20.04

Base Dissociation Constant (pKb)

9.42

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.60

V015-1352 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V015-1352 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-1352?
Check Price and Availability of V015-1352, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-1352 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-1352
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-1352
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-1352 available by request